drugset / Trial / NCT00002219

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

NCT00002219 ↗

Phase 2 Unknown 36 enrolled Gilead Sciences
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give adefovir (a new anti-HIV drug) plus nelfinavir to HIV-infected children who are already receiving other anti-HIV medications.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown — —
Subject Nelfinavir Other / unclassified — —
Background L-carnitine Other / unclassified — —